Management of schizophrenia patients in acute setting – a multinational survey of prescription patterns in five European countries
Despite the prevalence of negative or affective symptoms in FEP and relapsed patients, traditional antipsychotics remain the most prescribed treatments. Non-adherence and variability in LAI usage highlight the need for improved symptom-specific approaches and standardised LAI protocols.
Authors
- Irene Gabarda-Inat
- Libor Ustohal (ORCID: https://orcid.org/0000-0001-9465-0626)
- Małgorzata Urban‐Kowalczyk (ORCID: https://orcid.org/0000-0002-7016-636X)
- Petros Petrikis (ORCID: https://orcid.org/0000-0002-4236-2718)
- Elena Alvárez‐Barón
- Andrea Amerio (ORCID: https://orcid.org/0000-0002-3439-340X)
- Miquel Bioque (ORCID: https://orcid.org/0000-0001-6887-7149)
Institutions
- University of Ioannina (GR)
- Masaryk University (CZ)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University Hospital Brno (CZ)
- Hospital Clínic de Barcelona (ES)
- Medical University of Lodz (PL)
- Ospedale Policlinico San Martino (IT)
- Angelini Pharma (Italy) (IT)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- International Journal of Psychiatry in Clinical Practice
- Published
- 2025-12-14
- DOI
- https://doi.org/10.1080/13651501.2025.2594101
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00